These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1250664)

  • 41. Generic equivalents: issues and concerns.
    Lamy PP
    J Clin Pharmacol; 1986; 26(5):309-16. PubMed ID: 3700686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Equivalency of drugs and the problem of biological availability].
    Hirtz J
    Rev Prat; 1973 Nov; 23(53):7-10. PubMed ID: 4802222
    [No Abstract]   [Full Text] [Related]  

  • 43. Survey shows hospitals expand generic drug use.
    Jaffe MO
    Health Care Week; 1979 Feb; 2(30):1, 3. PubMed ID: 10240113
    [No Abstract]   [Full Text] [Related]  

  • 44. A case for generic prescribing?
    Birkett DJ; Robson RA
    Med J Aust; 1983 Jul; 2(2):92-3. PubMed ID: 6679056
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evaluation of the physiological availability of drug substances in capsules].
    Mikhaĭlova GS
    Farmatsiia; 1975; 24(1):78-82. PubMed ID: 770209
    [No Abstract]   [Full Text] [Related]  

  • 46. Status of generic substitution: problematic drug classes reviewed.
    Ross MB
    Hosp Formul; 1989 Aug; 24(8):441-4, 447-9. PubMed ID: 10294356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic batch certification and bioequivalence.
    DeSante KA; DiSanto AR; Chodos DJ; Stoll RG
    JAMA; 1975 Jun; 232(13):1349-51. PubMed ID: 1173399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FDA drug list: key to generic substitution.
    FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescribing trends in internal medicine.
    Uppal R; Nayak P; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):375-6. PubMed ID: 6469426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generic drugs provide no big savings so far in nation's health bill.
    Lublin JS; Jaroslovsky R
    Wall St J Midwest Ed; 1978 Dec; 59(38):1, 19. PubMed ID: 10239001
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmaceuticals issue brief: narrow therapeutic index drugs.
    Hackney C
    Issue Brief Health Policy Track Serv; 2000 Jul; ():1-5. PubMed ID: 11073428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prescription versus cheapest drug substitution.
    Lepp BA; Defelice SL
    N Y State J Med; 1975 Jan; 75(1):133-5, 146. PubMed ID: 1053813
    [No Abstract]   [Full Text] [Related]  

  • 53. Inherent risk and market acceptance of generic drug products.
    Carroll NV; Wolfgang AP
    J Health Care Mark; 1989 Dec; 9(4):48-51. PubMed ID: 10296580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. When do differences in dissolution profiles predict clinical problems?
    Ngo SN
    J Clin Pharm Ther; 2007 Apr; 32(2):111-2. PubMed ID: 17381660
    [No Abstract]   [Full Text] [Related]  

  • 55. Drugs, drug products and prescribing habits.
    Wade DN
    Drugs; 1971; 2(5):447-53. PubMed ID: 4948544
    [No Abstract]   [Full Text] [Related]  

  • 56. [Generic prescription].
    Olesgaard P
    Ugeskr Laeger; 1991 Jul; 153(31):2158-60. PubMed ID: 1866824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generics--is there a choice?
    Postgrad Med; 1978 Jul; 64(1):37. PubMed ID: 673970
    [No Abstract]   [Full Text] [Related]  

  • 58. Mental health and the elderly: new biopharmaceutic considerations.
    Cabana BE
    Health Aff (Millwood); 1983; 2(3):33-8. PubMed ID: 6654313
    [No Abstract]   [Full Text] [Related]  

  • 59. Brand names.
    Marler EE
    Lancet; 1972 Oct; 2(7780):757. PubMed ID: 4116163
    [No Abstract]   [Full Text] [Related]  

  • 60. The new 'bioequivalence and bioavailability' regulations.
    Gregory DR
    J Leg Med (N Y); 1977 May; 5(5):38-9. PubMed ID: 301162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.